Bracco Diagnostic Inc. Company Profile

16:47 EDT 23rd March 2018 | BioPortfolio

Bracco Imaging S.p.A., part of the Bracco Group, is one of the world’s leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging develops, manufactures and markets diagnostic imaging agents and solutions that meet medical needs.

News Articles [258 Associated News Articles listed on BioPortfolio]

Bracco Imaging reinforces its portfolio in Interventional Oncology

MILAN, March 3, 2018/PRNewswire/ -- Bracco Imaging S.p.A., a global leader in diagnostic imaging, announced today a strategic partnership with R.A.W. S.r.l. - an Read more...

Bracco Imaging buys SurgVision

Bracco Imaging SPA acquired privately held diagnostic imaging firm SurgVision BV for an undisclosed sum.

Bracco Imaging refuerza su cartera de oncología intervencionista

MILÁN, 4 de marzo de 2018 /PRNewswire/ -- Bracco Imaging S.p.A., líder mundial en dispositivos de diagnóstico por imagen, ha anunciado hoy una colaboración estratégica con Read more...

Bracco Imaging verstärkt sein Portfolio bei interventioneller Onkologie

MAILAND, 3. März 2018 /PRNewswire/ -- Bracco Imaging S.p.A., ein weltweit führendes Unternehmen bei diagnostischer Bildgebung, gab heute eine strategische Partnerschaft mit R.A.W. S.r.l. bekannt, ...

Bracco Imaging announces acquisition of SurgVision

Netherlands-based startup SurgVision was acquired by Bracco Imaging for undisclosed terms.  -More- 

Bracco Imaging partners with R.A.W to expand interventional oncology portfolio

Bracco Imaging has partnered with Italian company R.A.W. to expand its portfolio of solutions for interventional oncology.

Bracco Imaging SpA Medical Equipment Deals and Alliances Profile [Report Updated: 08022018] Prices from USD $250

SummaryBracco Imaging SpA Bracco, a subsidiary of Bracco SpA is a provider of diagnostic imaging solutions. The company offers diagnostic imaging, bracco pharma and health services. It offers solution...

ACIST Medical Systems Announces Approval and Launch of Next-Generation FFR System

ACIST RXi® Mini™ System Seamlessly Integrates with Cath Lab Hemodynamic System and FFR Software ACIST Medical Systems, Inc., a Bracco Group Company, today announced the ...

Drugs and Medications [28 Associated Drugs and Medications listed on BioPortfolio]

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Chromitope sodium [BRACCO DIAGNOSTICS INC.]

CHROMITOPE Sodium Sodium Chromate Cr 51 Injection USP

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

PubMed Articles [1017 Associated PubMed Articles listed on BioPortfolio]

Examining the diagnostic utility of the DSM-5 PTSD symptoms among male and female returning veterans.

Posttraumatic stress disorder (PTSD) diagnostic criteria have been criticized for including symptoms that overlap with commonly comorbid disorders, which critics argue undermines the validity of the d...

The Implication of Diagnostic Errors.

Diagnostic errors are mistakes in the diagnostic process that lead to a misdiagnosis, a missed diagnosis, or a delayed diagnosis. While the past decade's impetus to improve patient safety has focused ...

Beyond accuracy: hidden motives in diagnostic testing.

Diagnostic decision-making is usually disease-focussed and intended to examine the patient's medical condition accurately. But diagnostic interventions may serve further purposes that are not yet full...

Changes in symptoms of anxiety and depression following diagnostic angiography - a prospective cohort study.

Coronary angiography is the gold standard diagnostic test for coronary artery disease (CAD), and the diagnostic results can have an immediate effect on symptoms. The aim of this study was to explore t...

Improvement of diagnostic performance of pathologists by reducing the number of pathologists responsible for thyroid fine needle aspiration cytology: An institutional experience.

Various efforts have been made to improve the diagnostic accuracy of thyroid fine needle aspiration (FNA) cytology. We changed the diagnostic system by reducing the number of pathologists responsible ...

Clinical Trials [1892 Associated Clinical Trials listed on BioPortfolio]

RIGENERA 2.0 Trial

Study Objectives: To determine whether, in patients with large acute myocardial infarction undergoing primary or rescue angioplasty, the administration of subcutaneous Lenograstim [recombi...

Diagnostic Agreement of iFR and QFR.

A Prospective, observational, single center diagnostic study to investigate the the diagnostic agreement between QFR and the pressure wire-based iFR in a real world setting.

Influence of Diagnostic Errors on the Prognosis of Acute Pulmonary Embolism

Diagnostic errors have been reported frequently in patient with pulmonary embolism since symptoms are not specific. However, there is only scarce evidence that the delay associated with di...

Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors

This clinical study is designed to evaluate the diagnostic performance of VisioCyt test, which would improve the early diagnosis of bladder cancer in order to optimize the management of in...

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

RATIONALE: New diagnostic procedures such as computed tomographic colonography may provide a less invasive method of identifying patients who have colorectal neoplasia. PURPOSE: Diagnosti...

Companies [976 Associated Companies listed on BioPortfolio]

Bracco Diagnostic Inc.

Bracco Imaging S.p.A., part of the Bracco Group, is one of the world’s leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging dev...

Bracco Diagnostics Inc.

Bracco Imaging S.p.A., part of the Bracco Group, is one of the world’s leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging dev...

Bracco Imaging S.p.A.

Bracco Imaging S.p.A. is one of the World’s leading companies in the diagnostic imaging business. Bracco Imaging develops, manufactures and markets diagnostic imaging agents ...

Bracco Diagnostics Inc

Bracco, founded in 1927 by the family who gave it its name and which has been at its helm for three generations and still runs it today, is an integrated Healthcare Group, world leader in global solut...

ACIST Medical Systems Inc.

ACIST Medical Systems, Inc. is a pioneering interventional and diagnostic technology company with a portfolio of advanced products, including the world’s first Rapid Exchange...

More Information about "Bracco Diagnostic Inc." on BioPortfolio

We have published hundreds of Bracco Diagnostic Inc. news stories on BioPortfolio along with dozens of Bracco Diagnostic Inc. Clinical Trials and PubMed Articles about Bracco Diagnostic Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bracco Diagnostic Inc. Companies in our database. You can also find out about relevant Bracco Diagnostic Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record